Disinfection and Sterilization in Health Care Facilities: An Overview and Current Issues

Infectious Disease Clinics of North America

Volumn 30, Issue 3, 2016, Pages 609-637

  Rutala, William A ^a,b   Weber, David J ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Disinfection; Health care facilities; Sterilization

Indexed keywords

ALCOHOL; CHLORINE; ETHYLENE OXIDE; GLUTARALDEHYDE; HYDROGEN PEROXIDE; HYPOCHLORITE SODIUM; IODOPHOR; OZONE; PERACETIC ACID; PHTHALALDEHYDE; QUATERNARY AMMONIUM DERIVATIVE; DISINFECTANT AGENT;

ACINETOBACTER; BIOFILM; BIOTERRORISM; BRONCHOSCOPE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CLEANING; CLOSTRIDIUM DIFFICILE INFECTION; COLONY FORMING UNIT; CYSTOSCOPE; DISEASE TRANSMISSION; DISINFECTION; DUODENOSCOPE; ELECTROCHEMICAL ANALYSIS; ENDOSCOPE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; ENTEROBACTERIACEAE INFECTION; EPIDEMIC; HEALTH CARE; HEALTH CARE FACILITY; HEALTHCARE ASSOCIATED INFECTION; HUMAN; INFECTION CONTROL; INSTRUMENT STERILIZATION; LARYNGOSCOPE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL CONTAMINATION; NOROVIRUS; PATIENT CARE; PEPTOCLOSTRIDIUM DIFFICILE; REVIEW; RISK ASSESSMENT; STETHOSCOPE; ULTRAVIOLET RADIATION; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS; VAPORIZER; WART VIRUS; WASTE MANAGEMENT; WATER VAPOR; STANDARDS;

DISINFECTANTS; DISINFECTION; ENDOSCOPES; HEALTH FACILITIES; HUMANS; STERILIZATION;

EID: 84990065806     PISSN: 08915520     EISSN: 15579824     Source Type: Journal    
DOI: 10.1016/j.idc.2016.04.002     Document Type: Review

References (107)

1. 1 Centers for Disease Control and Prevention. National hospital discharge survey: 2010 table, procedures by selected patient characteristics-number by procedure category and age. 2010.
2. 2 Peery, A.F., Dellon, E.S., Lund, J., et al. Burden of gastrointestinal disease in the United States: 2012 update. Gastroenterology 143 (2012), 1179–1187.
3. 3 Epstein, L., Hunter, J.C., Arwady, M.A., et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 312 (2014), 1447–1455.
4. 4 Wendorf, K.A., Kay, M., Baliga, C., et al. Endoscopic retrograde cholangiopancreatography-associated AmpC Escherichia coli outbreak. Infect Control Hosp Epidemiol 36 (2015), 634–642.
5. 5 Ofstead, C.L., Wetzler, H.P., Snyder, A.K., et al. Endoscope reprocessing methods: a prospective study on the impact of human factors and automation. Gastroenterol Nurs 33 (2010), 304–311.
6. 6 Kovaleva, J., Peters, F.T., van der Mei, H.C., et al. Transmission of infection by flexible gastrointestinal endoscopy and bronchoscopy. Clin Microbiol Rev 26 (2013), 231–254.
7. 7 Rutala, W.A., Weber, D.J., How to assess risk of disease transmission to patients when there is a failure to follow recommended disinfection and sterilization guidelines. Infect Control Hosp Epidemiol 28 (2007), 146–155.
8. 8 Weber, D.J., Rutala, W.A., Lessons learned from outbreaks and pseudo-outbreaks associated with bronchoscopy. Infect Control Hosp Epidemiol 33 (2012), 230–234.
9. 9 Centers for Disease Control and Prevention. Immediate need for healthcare facilities to review procedures for cleaning, disinfecting, and sterilizing reusable medical devices. 2015. Available at: http://emergency.cdc.gov/han/han00382.asp. Accessed 18 May, 2016.
10. 10 Rutala, W.A., Weber, D.J., Disinfection, sterilization and control of hospital waste. Bennett, J.E., Dolan, R., Blaser, M.J., (eds.) Principles and practice of infectious diseases, 2015, Elsevier Saunders, Philadelphia, 3294–3309.
11. 11 Rutala, W.A., Weber, D.J., Disinfection, Sterilization and Antisepsis: An Overview. Am J Infect Control 44 (2016), e1–e66.
12. 12 Rutala, W.A., Weber, D.J., Cleaning, disinfection and sterilization. Grota, P., (eds.) APIC text of infection control and epidemiology, 4th edition, 2014, Association for Professionals in Infection Control and Epidemiology, Inc., Washington, DC, 31.1–31.15.
13. 13 Rutala, W.A., Weber, D.J., HICPAC, Guideline for disinfection and sterilization in healthcare facilities, 2008. 2008, Centers for Disease Control and Prevention, Atlanta (GA) Available at: http://www.cdc.gov/hicpac/pdf/guidelines/Disinfection_Nov_2008.pdf.
14. 14 Rutala WA, Weber DJ. Disinfection and sterilization in healthcare facilities. In: Han J, editor Practical healthcare epidemiology. 4th edition: University of Chicago Press, in press.
15. 15 Spaulding, E.H., Chemical disinfection of medical and surgical materials. Lawrence, C., Block, S.S., (eds.) Disinfection, sterilization, and preservation, 1968, Lea & Febiger, Philadelphia, 517–531.
16. 16 Sehulster, L., Chinn, R.Y.W., Healthcare Infection Control Practices Advisory Committee, Guidelines for environmental infection control in health-care facilities. MMWR Morb Mortal Wkly Rep 52 (2003), 1–44.
17. 17 Rutala, W.A., Weber, D.J., Disinfection and sterilization of prion-contaminated medical instruments, reply to Belay. Infect Control Hosp Epidemiol 31 (2010), 1306–1307.
18. 18 Rutala, W.A., Gergen, M.F., Weber, D.J., Efficacy of a washer-disinfector in eliminating healthcare-associated pathogens from surgical instruments. Infect Control Hosp Epidemiol 35 (2014), 883–885.
19. 19 Food and Drug Administration. FDA-cleared sterilants and high level disinfectants with general claims for processing reusable medical and dental devices, March 2015. Available at: http://www.fda.gov/MedicalDevices/DeviceRegulationandGuidance/ReprocessingofReusableMedicalDevices/ucm437347.htm. Accessed 19 May, 2016.
20. 20 Rutala WA, Weber DJ. Disinfection and sterilization in healthcare facilities. In: Han J, ed. SHEA practical healthcare epidemiology University of Chicago Press.
21. 21 Kohn, W.G., Collins, A.S., Cleveland, J.L., et al. Guidelines for infection control in dental health-care settings–2003. MMWR Recomm Rep 52 (2003), 1–61.
22. 22 McDonnell, G., Burke, P., Disinfection: is it time to reconsider Spaulding?. J Hosp Infect 78 (2011), 163–170.
23. 23 Food and Drug Administration. Brief summary of the gastroenterology and urology devices panel meeting. 2015.
24. 24 Rutala, W.A., Weber, D.J., Gastrointestinal endoscopes: a need to shift from disinfection to sterilization?. JAMA 312 (2014), 1405–1406.
25. 25 Rutala, W.A., Weber, D.J., ERCP scopes: what can we do to prevent infections?. Infect Control Hosp Epidemiol 36 (2015), 643–648.
26. 26 Tosh, P.K., Disbot, M., Duffy, J.M., et al. Outbreak of Pseudomonas aeruginosa surgical site infections after arthroscopic procedures: Texas, 2009. Infect Control Hosp Epidemiol 32 (2011), 1179–1186.
27. 27 Rutala, W.A., Gergen, M.F., Weber, D.J., Microbial contamination on used surgical instruments. Infect Control Hosp Epidemiol 35 (2014), 1068–1070.
28. 28 Rutala, W.A., Gergen, M.F., Weber, D.J., Disinfection of a probe used in ultrasound-guided prostate biopsy. Infect Control Hosp Epidemiol 28 (2007), 916–919.
29. 29 Rutala, W.A., Gergen, M.F., Bringhurst, J., et al. Effective high-level disinfection of cystoscopes: is perfusion of channels required?. Infect Control Hosp Epidemiol 37:2 (2016), 228–231.
30. 30 Rutala, W.A., Gergen, M.F., Weber, D.J., Disinfection of an infrared coagulation device used to treat hemorrhoids. Am J Infect Control 40 (2012), 78–79.
31. 31 Weber, D.J., Rutala, W.A., Role of environmental contamination in the transmission of vancomycin-resistant enterococci. Infect Control Hosp Epidemiol 18 (1997), 306–309.
32. 32 Weber, D.J., Rutala, W.A., Miller, M.B., et al. Role of hospital surfaces in the transmission of emerging health care-associated pathogens: norovirus, Clostridium difficile, and Acinetobacter species. Am J Infect Control 38 (2010), S25–S33.
33. 33 Weber, D.J., Rutala, W.A., Sickbert-Bennett, E.E., Outbreaks associated with contaminated antiseptics and disinfectants. Antimicrob Agents Chemother 51 (2007), 4217–4224.
34. 34 Rutala, W.A., Cole, E.C., Thomann, C.A., et al. Stability and bactericidal activity of chlorine solutions. Infect Control Hosp Epidemiol 19 (1998), 323–327.
35. 35 Petersen, B.T., Chennat, J., Cohen, J., et al. Multisociety guideline on reprocessing flexible GI endoscopes: 2011. Infect Control Hosp Epidemiol 32 (2011), 527–537.
36. 36 Society of Gastroenterology Nurses and Associates I, Standards of infection control and reprocessing of flexible gastrointestinal endoscopes. Gastroenterol Nurs 36 (2013), 293–303.
37. 37 Muscarella, L.F., Risk of transmission of carbapenem-resistant Enterobacteriaceae and related “superbugs” during gastrointestinal endoscopy. World J Gastrointest Endosc 6 (2014), 457–474.
38. 38 Ofstead, C.L., Wetzler, H.P., Doyle, E.M., et al. Persistent contamination on colonoscopes and gastroscopes detected by biologic cultures and rapid indicators despite reprocessing performed in accordance with guidelines. Am J Infect Control 43 (2015), 794–801.
39. 39 Carbonne, A., Thiolet, J.M., Fournier, S., et al. Control of a multi-hospital outbreak of KPC-producing Klebsiella pneumoniae type 2 in France, September to October 2009. Euro Surveill, 15, 2010 [pii:19734].
40. 40 Roberts, C.G., Studies on the bioburden on medical devices and the importance of cleaning. Rutala, W.A., (eds.) Disinfection, sterilization and antisepsis: principles and practices in healthcare facilities, 2000, Association for Provessionals in Infection Control and Epidemiology, Washington, DC, 63–69.
41. 41 Alfa, M.J., Degagne, P., Olson, N., Worst-case soiling levels for patient-used flexible endoscopes before and after cleaning. Am J Infect Control 27 (1999), 392–401.
42. 42 Rutala, W.A., Weber, D.J., FDA labeling requirements for disinfection of endoscopes: a counterpoint. Infect Control Hosp Epidemiol 16 (1995), 231–235.
43. 43 Food and Drug Administration. Brief summary of the gastroeneterology and urology devices panel meeting, May 14-15, 2015. Available at: http://www.fda.gov/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/ucm445590.htm. Accessed 18 May, 2016.
44. 44 Pajkos, A.V.K., Cossart, Y., Is biofilm accumulation on endoscope tubing a contributor to the failure of cleaning and decontamination. J Hosp Infect, 58, 2004, 224.
45. 45 Roberts, C.G., The role of biofilms in reprocessing medical devices. WA, R., (eds.) Disinfection, sterilization and antisepsis: principles, practices, current issues, new research, and new technologies, 2010, Association for Professionals in Infection Control and Epidemiology, Washington, DC, 223–229.
46. 46 Neves, M.S., daSilva, M.G., Ventura, G.M., et al. Effectiveness of current disinfection procedures against biofilm on contaminated GI endoscopes. Gastrointest Endosc 83:5 (2016), 944–953.
47. 47 Ren-Pei, W., Hui-Jun, X., Ke, Q., et al. Correlation between the growth of bacterial biofilm in flexible endoscopes and endoscope reprocessing methods. Am J Infect Control 42 (2014), 1203–1206.
48. 48 Agrawal, D., Muscarella, L.F., Delayed reprocessing of endoscopes. Gastrointest Endosc 73 (2011), 853–854.
49. 49 Rutala, W.A., Weber, D.J., Outbreaks of carbapenem-resistant Enteriobacteriaceae infections associated with duodenoscopes: what can we do to prevent infections?. Am J Infect Control 44:5 Suppl (2016), e47–e51.
50. 50 Otter, J.A., Yezli, S., French, G.L., The role played by contaminated surfaces in the transmission of nosocomial pathogens. Infect Control Hosp Epidemiol 32 (2011), 687–699.
51. 51 Boyce, J.M., Environmental contamination makes an important contribution to hospital infection. J Hosp Infect 65:Suppl 2 (2007), 50–54.
52. 52 Weber, D.J., Anderson, D.J., Sexton, D.J., et al. Role of the environment in the transmission of Clostridium difficile in health care facilities. Am J Infect Control 41 (2013), S105–S110.
53. 53 Rutala, W.A., Weber, D.J., Disinfectants used for environmental disinfection and new room decontamination technology. Am J Infect Control 41 (2013), S36–S41.
54. 54 Stiefel, U., Cadnum, J.L., Eckstein, B.C., et al. Contamination of hands with methicillin-resistant Staphylococcus aureus after contact with environmental surfaces and after contact with the skin of colonized patients. Infect Control Hosp Epidemiol 32 (2011), 185–187.
55. 55 Carling, P., Methods for assessing the adequacy of practice and improving room disinfection. Am J Infect Control 41 (2013), S20–S25.
56. 56 Huang, S.S., Datta, R., Platt, R., Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 166 (2006), 1945–1951.
57. 57 Shaughnessy, M.K., Micielli, R.L., DePestel, D.D., et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol 32 (2011), 201–206.
58. 58 Donskey, C.J., Does improving surface cleaning and disinfection reduce health care-associated infections?. Am J Infect Control 41 (2013), S12–S19.
59. 59 Carling, P.C., Bartley, J.M., Evaluating hygienic cleaning in health care settings: what you do not know can harm your patients. Am J Infect Control 38 (2010), S41–S50.
60. 60 Boyce, J.M., Havill, N.L., Dumigan, D.G., et al. Monitoring the effectiveness of hospital cleaning practices by use of an adenosine triphosphate bioluminescence assay. Infect Control Hosp Epidemiol 30 (2009), 678–684.
61. 61 Hota, B., Blom, D.W., Lyle, E.A., et al. Interventional evaluation of environmental contamination by vancomycin-resistant enterococci: failure of personnel, product or procedure?. J Hosp Infect 71 (2009), 123–131.
62. 62 Goodman, E.R., Platt, R., Bass, R., et al. Impact of an environmental cleaning intervention on the presence of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci on surfaces in intensive care unit rooms. Infect Control Hosp Epidemiol 29 (2008), 593–599.
63. 63 Eckstein, B.C., Adams, D.A., Eckstein, E.C., et al. Reduction of Clostridium difficile and vancomycin-resistant Enterococcus contamination of environmental surfaces after an intervention to improve cleaning methods. BMC Infect Dis, 7, 2007, 61.
64. 64 Leas BF, SN, Han JH, et al. Environmental cleaning for the prevention of healthcare-associated infection. Technical brief No. 22 (prepared by the ECRI Institute – Penn Agency for Healthcare Research and Quality. Available at: http://effectivehealthcare.ahrq.gov/index.cfm/search-for-guides-reviews-and-reports/?pageaction=displayproduct&productid=1951. Accessed 18 May, 2016.
65. 65 Huslage, K., Rutala, W.A., Sickbert-Bennett, E., et al. A quantitative approach to defining “high-touch” surfaces in hospitals. Infect Control Hosp Epidemiol 31 (2010), 850–853.
66. 66 Huslage, K., Rutala, W.A., Gergen, M.F., et al. Microbial assessment of high-, medium-, and low-touch hospital room surfaces. Infect Control Hosp Epidemiol 34 (2013), 211–212.
67. 67 Memarzadeh, F., Olmsted, R.N., Bartley, J.M., Applications of ultraviolet germicidal irradiation disinfection in health care facilities: effective adjunct, but not stand-alone technology. Am J Infect Control 38 (2010), S13–S24.
68. 68 Nerandzic, M.M., Thota, P., Sankar, C.T., et al. Evaluation of a pulsed xenon ultraviolet disinfection system for reduction of healthcare-associated pathogens in hospital rooms. Infect Control Hosp Epidemiol 36 (2015), 192–197.
69. 69 Rutala, W.A., Gergen, M.F., Weber, D.J., Room decontamination with UV radiation. Infect Control Hosp Epidemiol 31 (2010), 1025–1029.
70. 70 Rutala, W.A., Gergen, M.F., Tande, B.M., et al. Room decontamination using an ultraviolet-C device with short ultraviolet exposure time. Infect Control Hosp Epidemiol 35 (2014), 1070–1072.
71. 71 Nerandzic, M.M., Cadnum, J.L., Pultz, M.J., et al. Evaluation of an automated ultraviolet radiation device for decontamination of Clostridium difficile and other healthcare-associated pathogens in hospital rooms. BMC Infect Dis, 10, 2010, 197.
72. 72 Boyce, J.M., Havill, N.L., Moore, B.A., Terminal decontamination of patient rooms using an automated mobile UV light unit. Infect Control Hosp Epidemiol 32 (2011), 737–742.
73. 73 Boyce, J.M., Havill, N.L., Otter, J.A., et al. Impact of hydrogen peroxide vapor room decontamination on Clostridium difficile environmental contamination and transmission in a healthcare setting. Infect Control Hosp Epidemiol 29 (2008), 723–729.
74. 74 French, G.L., Otter, J.A., Shannon, K.P., et al. Tackling contamination of the hospital environment by methicillin-resistant Staphylococcus aureus (MRSA): a comparison between conventional terminal cleaning and hydrogen peroxide vapour decontamination. J Hosp Infect 57 (2004), 31–37.
75. 75 Bartels, M.D., Kristoffersen, K., Slotsbjerg, T., et al. Environmental methicillin-resistant Staphylococcus aureus (MRSA) disinfection using dry-mist-generated hydrogen peroxide. J Hosp Infect 70 (2008), 35–41.
76. 76 Hall, L., Otter, J.A., Chewins, J., et al. Use of hydrogen peroxide vapor for deactivation of Mycobacterium tuberculosis in a biological safety cabinet and a room. J Clin Microbiol 45 (2007), 810–815.
77. 77 Hardy, K.J., Gossain, S., Henderson, N., et al. Rapid recontamination with MRSA of the environment of an intensive care unit after decontamination with hydrogen peroxide vapour. J Hosp Infect 66 (2007), 360–368.
78. 78 Johnston, M.D., Lawson, S., Otter, J.A., Evaluation of hydrogen peroxide vapour as a method for the decontamination of surfaces contaminated with Clostridium botulinum spores. J Microbiol Methods 60 (2005), 403–411.
79. 79 Heckert, R.A., Best, M., Jordan, L.T., et al. Efficacy of vaporized hydrogen peroxide against exotic animal viruses. Appl Environ Microbiol 63 (1997), 3916–3918.
80. 80 Klapes, N.A., Vesley, D., Vapor-phase hydrogen peroxide as a surface decontaminant and sterilant. Appl Environ Microbiol 56 (1990), 503–506.
81. 81 Bates, C.J., Pearse, R., Use of hydrogen peroxide vapour for environmental control during a Serratia outbreak in a neonatal intensive care unit. J Hosp Infect 61 (2005), 364–366.
82. 82 Shapey, S., Machin, K., Levi, K., et al. Activity of a dry mist hydrogen peroxide system against environmental Clostridium difficile contamination in elderly care wards. J Hosp Infect 70 (2008), 136–141.
83. 83 Falagas, M.E., Thomaidis, P.C., Kotsantis, I.K., et al. Airborne hydrogen peroxide for disinfection of the hospital environment and infection control: a systematic review. J Hosp Infect 78 (2011), 171–177.
84. 84 Weber DJ, Rutala W, Anderson DJ, et al. Effectiveness of UV devices and hydrogen peroxide systems for terminal room decontamination: focus on clinical trials. Am J Infect Control, 2016.;44(5 Suppl):e77-e84.
85. 85 Rutala, W.A., Weber, D.J., Selection of the ideal disinfectant. Infect Control Hosp Epidemiol 35 (2014), 855–865.
86. 86 Weber, D.J., Rutala, W.A., Assessing the risk of disease transmission to patients when there is a failure to follow recommended disinfection and sterilization guidelines. Am J Infect Control 41 (2013), S67–S71.
87. 87 Meyers, J., Ryndock, E., Conway, M.J., et al. Susceptibility of high-risk human papillomavirus type 16 to clinical disinfectants. J Antimicrob Chemother 69:6 (2014), 1546–1550.
88. 88 Ryndock, E., Robison, R., Meyers, C., Susceptibility of HPV 16 and 18 to high-level disinfectants indicated for semi-critical ultrasound probes. J Med Virol 88:6 (2015), 1076–1080.
89. 89 Rutala, W.A., Gergen, M.F., Sickbert-Bennett, E.E., Effectiveness of a hydrogen peroxide mist (Trophon®) system in inactivating healthcare pathogens on surface and endocavitary probes. Infect Control Hosp Epidemiol 37:5 (2016), 613–614.
90. 90 Vickery, K., Gorgis, V.Z., Burdach, J., et al. Evaluation of an automated high-level disinfection technology for ultrasound transducers. J Infect Public Health 7 (2014), 153–160.
91. 91 Bringhurst, J., Disinfection and sterilization in physician practices and specialty clinics. Am J Infect Control 44 (2016), e63–e67.
92. 92 Rutala, W.A., Weber, D.J., Reprocessing semicritical items: current issues and new technologies. Am J Infect Control 44:5 Suppl (2016), e53–e62.
93. 93 Anonymous. McGrath MAC video laryngoscope operator's manual. Available at: https://www.physio-control.com/uploadedFiles/Physio85/Contents/Emergency_Medical_Care/Products/PreHospital/MAC%20EMS%20IFU.pdf. Access 18 May, 2016.
94. 94 Wendelboe, A.M., Bauchman, J., Blossom, D.B., et al. Outbreak of cystoscopy related infections with Pseudomonas aeurginosa: New Mexico, 2007. J Urol 180 (2008), 588–592.
95. 95 Muscarella, L.F., Recommendations to resolve inconsistent guidelines for the reprocessing of sheathed and unsheathed rigid laryngoscopes. Infect Control Hosp Epidemiol 28 (2007), 504–507.
96. 96 Muscarella, L.F., Prevention of disease transmission during flexible laryngoscopy. Am J Infect Control 35 (2007), 536–544.
97. 97 Muscarella, L.F., Reassessment of the risk of healthcare-acquired infection during rigid laryngoscopy. J Hosp Infect 68 (2008), 101–107.
98. 98 Call, T.R., Auerbach, F.J., Riddell, S.W., et al. Nosocomial contamination of laryngoscope handles: challenging current guidelines. Anesth Analg 109 (2009), 479–483.
99. 99 Williams, D., Dingley, J., Jones, C., et al. Contamination of laryngoscope handles. J Hosp Infect 74 (2010), 123–128.
100. 100 Phillips, R.A., Monaghan, W.P., Incidence of visible and occult blood on laryngoscope blades and handles. AANA J 65 (1997), 241–246.
101. 101 Anonymous. GlideScope. Available at: http://www.verathon.com/assets/0900-4200-02-60.pdf. Accessed 18 May, 2016.
102. 102 Cook, B.W.M., Cutts, T.A., Nikiforuk, A.M., et al. Evaluating environmental persistence and disinfection of the Ebola virus Makona variant. Viruses 7 (2015), 1975–1986.
103. 103 Klein, M., DeForest, A., The inactivation of viruses by germicides. Chem Specialists Manuf Assoc Proc 49 (1963), 116–118.
104. 104 Rutala, W.A., Gergen, M.F., Weber, D.J., Sporicidal activity of a new low-temperature sterilization technology: the Sterrad 50 sterilizer. Infect Control Hosp Epidemiol 20 (1999), 514–516.
105. 105 Rutala, W.A., Stiegel, M.M., Sarubbi, F.A., et al. Susceptibility of antibiotic-susceptible and antibiotic-resistant hospital bacteria to disinfectants. Infect Control Hosp Epidemiol 18 (1997), 417–421.
106. 106 Anderson, R.L., Carr, J.H., Bond, W.W., et al. Susceptibility of vancomycin-resistant enterococci to environmental disinfectants. Infect Control Hosp Epidemiol 18 (1997), 195–199.
107. 107 Rutala, W.A., Barbee, S.L., Aguiar, N.C., et al. Antimicrobial activity of home disinfectants and natural products against potential human pathogens. Infect Control Hosp Epidemiol 21 (2000), 33–38.